Healthy Clinical Trial
Official title:
An Internet-administered Randomized Control Trial to Examine the Effects of Regular, Brief Meditation Practice on Mental Health and Well Being
Verified date | April 2024 |
Source | Stanford University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study will examine the effects of online meditation training on stress and anxiety in healthy participants. It will also examine the dose-response relationship between the amount of daily focused attention meditation practice and established mental health outcome measures.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | December 31, 2024 |
Est. primary completion date | September 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years - Able to follow basic instructions for prescreening and scheduling - Compliant with investigator instructions during the consent process and participation in the study - Is not already a regular meditation practitioner Exclusion Criteria: - Age <18 - People with a current diagnosis of psychiatric or neurological disorders - Be in current psychiatric treatment or medications - Hospitalized for psychiatric disorders in the past year or so. - Regular and long-term meditation practitioners - Non-English speaking - Non-USA mailing address to receive the activity tracker device - Vision or hearing impairment severe enough to interfere with study participation |
Country | Name | City | State |
---|---|---|---|
United States | Dept. of Psychiatry, Stanford University | Stanford | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University | Feldman Foundation CA, Institute for Meditation and Inner Harmony |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Generalize Anxiety Disorder Questionnaire Score | Anxiety as measured using Generalize Anxiety Disorder Questionnaire | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Primary | Change in Pittsburgh Sleep Quality Index Questionnaire Score | Sleep Quality measured using Pittsburgh sleep quality index (PSQI) | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Primary | Change in Mind Wandering Questionnaire Score | Mind wandering measured using the Mind Wandering Questionnaire | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Primary | Resting Heart Rate | Daily obtained from Activity Tracker wrist band | Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2) | |
Primary | Heart Rate Variability | Daily obtained from Activity Tracker wrist band | Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2) | |
Primary | Change in Stroop Test Score | Using the Stroop test, which measures the average reaction time between incongruent and congruent trials | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Primary | Change in N-back Test Score | Using the N-back test is a memory task where participants must remember letters from N trials ago. | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Secondary | Change in Stress Scale Measure Questionnaire Score | Stress measured using Perceived Stress Scale measure | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Secondary | Change in Depression Questionnaire Score | Depression measured using Patient Health Questionnaire | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Secondary | Change in Quality of Life Scale Measures Questionnaire Score | Quality of life measured using Quality of Life Scale measures | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Secondary | Change Social Connectedness Scale-Revised Questionnaire Score | Social Connectedness measured using Social Connectedness Scale-Revised | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Secondary | Change in Rumination Reflection Questionnaire Score | Rumination and reflection scales measured using Rumination Reflection Questionnaire | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Secondary | Change in Brief Strengths Scale Questionnaire Score | Strengths scale measured using Brief Strengths Scale measures individuals' Temperance Strength, Intellectual Strength, and Interpersonal Strength. | Twice (Baseline and week 8 for arm 1 and week 8 and week 16 for arm 2) | |
Secondary | Change in Sleep Quality Measure | Daily obtained from Activity Tracker wrist band | Daily (from baseline to week 8 for arm 1 and from week 8 to week 16 for arm 2) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |